insights_auto
Why is RGEN up 2.09%?
Dive Deeperchevron_right
RGEN:NASDAQ
Repligen Corp
$179.08
arrow_upward
+2.09%(+3.66) 1D
Oct 14, 2:15:56 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$175.42
High
$181.07
Low
$175.39
Mkt. cap
11.37B
Avg. vol.
1.22M
Volume
682.08K
P/E ratio
244.10
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
63.49M
No. of employees
2K
Open
$175.42
High
$181.07
Low
$175.39
Mkt. cap
11.37B
Avg. vol.
1.22M
Volume
682.08K
P/E ratio
244.10
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
63.49M
No. of employees
2K
News stories
From web sources and news partners
Stock Traders Daily
·
19 hours ago
(RGEN) Movement Within Algorithmic Entry Frameworks
GlobeNewswire
·
1 day ago
Repligen to Report Third Quarter 2026 Financial Results
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com